Patrick E. Burnett
Executive VP & Chief Medical OfficerDr. Patrick E. Burnett, MD, PhD, FAAD, is Chief Medical Officer of Arcutis Biotherapeutics Inc. since August 1, 2020 and serves as its Executive Vice President from December 2024, he also served as its Senior Vice President until December 2024. He was the Chief Medical Officer of Verrica Pharmaceuticals Inc. since April 2018 July 2020. Mr. Burnett joined Arcutis in August 2020. Dr. Burnett served at Sun Pharmaceuticals, where he was Associate Vice President of Clinical Development from September 2015 to March 2018, with oversight of the dermatology and rheumatology pipeline. Prior to Sun, Dr. Burnett was at Novartis from 2010 to August 2015 and served as Global Program Medical Director. He is a board certified dermatologist and was a member of the medical faculty at Vanderbilt University Medical Center as an Assistant Professor of Dermatology from 2004 to 2010. Dr. Burnett holds an M.D. and Ph.D. in neuroscience from Johns Hopkins School of Medicine and a B.S. in Biology and Biochemistry from the University of Iowa.
Positions
- Company NameArcutis Biotherapeutics, Inc.Stock CodeARQTPositionExecutive VP & Chief Medical OfficerColleagues
- TFTodd Franklin WatanabePresident, CEO & Director
- KRKeith R. LeonardIndependent Chairman of the Board
- BCBhaskar ChaudhuriCo-Founder & Director Emeritus
- LVLatha VairavanSenior VP & Chief Financial Officer
- MMMasaru MatsudaExecutive VP, Chief Legal Officer & Corporate Secretary
- TJTerrie J. CurranIndependent Director
- ADAmit D. MunshiIndependent Director
